Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
44.99 USD | -5.56% | -0.29% | +11.78% |
May. 10 | Baird Starts Soleno Therapeutics With Outperform Rating, $72 Price Target | MT |
May. 09 | Soleno Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 45.02M | Capitalization | 1.64B |
---|---|---|---|---|---|
Net income 2024 * | -96M | Net income 2025 * | -52M | EV / Sales 2024 * | - |
Net cash position 2024 * | 139M | Net cash position 2025 * | 99.6M | EV / Sales 2025 * | 34.2 x |
P/E ratio 2024 * |
-17.6
x | P/E ratio 2025 * |
-34.7
x | Employees | 33 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.86% |
Latest transcript on Soleno Therapeutics, Inc.
1 day | -5.56% | ||
1 week | -0.29% | ||
Current month | +0.74% | ||
1 month | +15.39% | ||
3 months | -8.80% | ||
6 months | +104.50% | ||
Current year | +11.78% |
Managers | Title | Age | Since |
---|---|---|---|
Anish Bhatnagar
CEO | Chief Executive Officer | 56 | 05-12-31 |
James Mackaness
DFI | Director of Finance/CFO | 60 | 19-11-13 |
Ernest Mario
CHM | Chairman | 85 | 07-08-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ernest Mario
CHM | Chairman | 85 | 07-08-02 |
Gwen Melincoff
BRD | Director/Board Member | 72 | 19-04-25 |
Bill Harris
BRD | Director/Board Member | 65 | 14-06-01 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 44.99 | -5.56% | 546,056 |
24-05-09 | 47.64 | +2.98% | 415,150 |
24-05-08 | 46.26 | -1.15% | 490,439 |
24-05-07 | 46.8 | +1.87% | 428,031 |
24-05-06 | 45.94 | +1.82% | 316,240 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.78% | 1.64B | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- SLNO Stock